{"database": "lobbying", "table": "lobbying_activities", "rows": [[2073090, "adbb4bf1-c92c-46b7-ad1b-80fd978b7a7b", "Q4", "THE SMITH-FREE GROUP, LLC", 35800, "BALLANTYNE BRANDS LLC", 2017, "fourth_quarter", "TOB", "H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text)\n\nDiscussions regarding the FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding \"Intended Uses\" (All Sections of full text)\n\nDiscussions regarding the FDA Implementation of P.L.1111-31 (All sections of full text)", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2018-01-19T13:42:32.237000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2073090"], "units": {}, "query_ms": 69.7336959419772, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}